This website uses cookies to enhance the user experience.
||
DIASORIN AB

DIASORIN AB993 032 468

Purchase and sale
Norwegian division of foreign business enterprise
plan 5 Solna Torg 19 SE-171 45 SOLNA, Sverige
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

DIASORIN AB

Operating
Diasorin | Molecular Diagnostics and Immunodiagnostic Specialist
Diasorin is the global leader in Molecular Diagnostics and Immunodiagnostics market. Discover all Diasorin’s diagnostic solutions.
Salg og markedsføring av IVD-produkter, samt teknisk support og service.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

CEO
MR

Mark Richard Jackman1973

Years since formation
18 years
since Sep 23, 2008
Type
Norwegian division of foreign business enterprise
VAT registered
Yes
Number of employees
0

Financials

Total operating income 2024
31,414,566
NOK
Annual total result 2024
2,994,506
NOK
Total equity 2024
2,841,878
NOK
Last update: Feb 13, 2026

Management

Management / administration

NameRoleShares
MR

Mark Richard Jackman

1973

Managing Director/CEO-

Board

NameRoleShares
D
DIASORIN AB
Information about the Company in the Home Country-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-
E
ENORA AS
Accountant-
Last update: Dec 3, 2025

Ownership

No available data

Financials

in NOK

Summary

Year2024202320222021
Total operating income
31,414,566
32,101,101
29,704,231
29,987,475
Annual Total Result
2,994,506
4,800,570
4,593,130
5,095,764
Total assets
6,251,134
8,339,044
3,989,766
4,550,054
Total liabilities
3,409,257
3,458,315
3,124,895
3,441,880
Total equity
2,841,878
4,880,729
864,870
1,108,174

P&L

Year2024202320222021
Total operating income
31,414,566
32,101,101
29,704,231
29,987,475
Total operating costs
27,575,456
25,931,294
23,799,854
23,437,356
Operating result
3,839,110
6,169,807
5,904,376
6,550,119
Financial income/costs
0
-15,230
-15,748
-17,088
Profit before tax
3,839,110
6,154,577
5,888,628
6,533,031
Total tax & extraordinary income/cost
844,604
1,354,007
1,295,498
1,437,267
Annual Total Result
2,994,506
4,800,570
4,593,130
5,095,764

Balance overview

Year2024202320222021
Total fixed assets
0
0
0
0
Total current assets
6,251,134
8,339,044
3,989,766
4,550,054
Total assets
6,251,134
8,339,044
3,989,766
4,550,054
Short term debt
3,409,257
3,458,315
3,124,895
3,441,880
Long term debt
0
0
0
0
Total liabilities
3,409,257
3,458,315
3,124,895
3,441,880
Contributed capital
0
0
0
0
Retained earnings
2,841,878
4,880,729
864,870
1,108,174
Total equity
2,841,878
4,880,729
864,870
1,108,174
Total equity and liabilities
6,251,134
8,339,044
3,989,766
4,550,054

Classification

21st company classification
BETA
Small company
Category
Type of organization
Norwegian division of foreign business enterprise
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods